Company intelligence / Profile preview

Novus Biologicals

Centennial, Colorado, United Statesnovusbio.com ↗

Ownership: Private
Employees: ~58
Development stage: Commercial

Overview

Novus Biologicals supplies over half a million antibodies and related reagents to the global life science community. Their products support basic and applied biomedical research but are not themselves drugs or clinical candidates.

Therapeutic areas: Other
Modalities: AntibodyProteinPeptideLysate (as research reagent)ELISA kit (as research reagent)Cell line (as research tool)
Industry: Non-Drug Biotech

Partnerships

Collaborates with academic researchers and licensors to commercialize unique biological materials

Beyond the preview

Go deeper on Novus Biologicals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novus Biologicals.